why choose us

First received: January 04, 2023

Clinical Trial: Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

Study Status: Completed

Recruit Status: RECRUITING

Condition: Coronary Artery Disease

Study Type: INTERVENTIONAL


Official Title: Tailoring Bleeding Reduction Approaches in Patients Undergoing Percutaneous Coronary Interventions: Comparative Pharmacodynamic Effects of Potent P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet T

Brief Summary: Two strategies have both proven to be effective in reducing bleeding complications while preserving efficacy compared with maintaining long-term DAPT with aspirin and a potent P2Y12 inhibitor: a) DAPT de-escalation (i.e., switching from prasugrel or ticagrelor to clopidogrel while maintaining aspirin) and b) potent P2Y12 inhibitor monotherapy (i.e., maintaining prasugrel or ticagrelor and dropping aspirin).These strategies have been tested in a number of trials and have led to changes in practice guidelines to…

Read more